Oxymatrine reverses epithelial-mesenchymal transition in breast cancer cells by depressing α?β3 integrin/FAK/PI3K/Akt signaling activation

Oxymatrine reverses epithelial-mesenchymal transition in breast cancer cells by depressing α?β3 integrin/FAK/PI3K/Akt signaling activation

Yan Chen,1–4,* Lin Chen,1,5,* Jing-Yu Zhang,1 Zong-Yue Chen,1 Ting-ting Liu,1 Yan-Yan Zhang,1–3 Ling-Yun Fu,1–4 Shuang-Qin Fan,1 Min-Qin Zhang,2–4 Shi-quan Gan,1–4 Nen-ling Zhang,1–4 Xiang-Chun Shen1–41The Department of Pharmacolo...

Full description

Bibliographic Details
Main Authors: Chen Y, Chen L, Zhang JY, Chen ZY, Liu T, Zhang YY, Fu LY, Fan SQ, Zhang MQ, Gan S, Zhang N, Shen XC
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:OncoTargets and Therapy
Subjects:
Oxymatrine
breast cancer
???3 integrin
epithelial-mesenchymal transition.
Online Access:https://www.dovepress.com/oxymatrine-reverses-epithelial-mesenchymal-transition-in-breast-cancer-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/oxymatrine-reverses-epithelial-mesenchymal-transition-in-breast-cancer-peer-reviewed-article-OTT

Similar Items